Skip to main contentSkip to navigation
Sirius Investors
Global Blood Therapeutics, Inc.

Global Blood Therapeutics, Inc.

GBT
NASDAQHealthcare

GBT Financial Statements & Analysis

Complete financial statements for GBT including income statement, balance sheet, and cash flow statement. Analyze GBT's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Financial Health Score

Financial Health Score

/100
Unlock score for free

Already registered? Sign in

Income Statement

Revenue
11.4%
Net Income
-4.1%
Gross Margin
-0.1%
Operating Margin
7.8%

Balance Sheet

Current Ratio
-19.3%
Debt to Equity
13.1%
Asset Turnover
11.3%

Cash Flow

Operating Cash Flow
0.0%
Net Cash Flow
-195.7%
Free Cash Flow
0.2%
Cash Flow to Debt
-0.1%

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q1 '22TTM Q2 '22ChangeImpact
Revenue210.87M234.86M11.4%
Gross Profit207.08M230.41M11.3%
Operating Income-289.60M-297.41M2.7%
Net Income-313.50M-326.38M4.1%
EPS-1.23-1.272.8%
EBITDA-280.11M-287.94M2.8%
Gross Margin98.20%98.10%0.1%
Operating Margin-137.34%-126.63%7.8%
Net Income Margin-148.67%-138.97%6.5%
R&D Expenses214.11M227.10M6.1%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q2 '22TTM Q1 '22TTM Q4 '21TTM Q3 '21TTM Q2 '21
Revenue234.86M210.87M194.75M
Gross Profit230.41M207.08M191.43M
Operating Income-297.41M-289.60M-287.92M
Net Income-326.38M-313.50M-307.01M
EPS-1.27-1.23-1.22
EBITDA-287.94M-280.11M-278.53M
Gross Margin98.10%98.20%98.30%
Operating Margin-126.63%-137.34%-147.84%
Net Income Margin-138.97%-148.67%-157.64%
R&D Expenses227.10M214.11M212.13M

Our detailed financial analysis helps investors understand GBT's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track GBT's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into GBT's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics
Global Blood Therapeutics, Inc. (GBT) Financial Statements (2026): Income, Balance Sheet & Cash Flow | Sirius Investors